GrahamJAHansenKKRabinowitzLGet al.Pyoderma gangrenosum in infants and children. Pediatr Dermatol1994; 11: 10–17.
2.
RothfussKSStangeEFHerrlingerKR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol2006; 12: 4819–4831.
3.
BraswellSFKostopoulosTCOrtega-LoayzaAG. Pathophysiology of pyoderma gangrenosum (PG): An updated review. J Am Acad Dermatol2015; 73: 691–698.
4.
SchochJJTolkachjovSNCappelJAet al.Pediatric pyoderma gangrenosum: a retrospective review of clinical features, etiologic associations, and treatment. Pediatr Dermatol2017; 34: 39–45.
5.
YeMJYeJM. Pyoderma gangrenosum: a review of clinical features and outcomes of 23 cases requiring inpatient management. Dermatol Res Pract2014; 2014: 461467–461467.
6.
BakelantsEvan der HilstJCorluyLet al.The diagnostic tangle of pyoderma gangrenosum: a case report and review of the literature. Neth J Med2014; 72: 541–544.
7.
HeuschkelRSalvestriniCBeattieRMet al.Guidelines for the management of growth failure in childhood inflammatory bowel disease. Inflamm Bowel Dis2008; 14: 839–849.
8.
KimBSMLiBTEngelAet al.Diagnosis of gastrointestinal bleeding: A practical guide for clinicians. World J Gastrointest Pathophysiol2014; 5: 467–478.
PatelFFitzmauriceSDuongCet al.Effective strategies for the management of pyoderma gangrenosum: a comprehensive review. Acta Derm Venereol2015; 95: 525–531.